|
ANKRD40 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71709999999825E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.168720E-04 |
| Normal-vs-Stage2 |
6.269700E-02 |
| Normal-vs-Stage3 |
1.71802999999748E-05 |
| Normal-vs-Stage4 |
5.56779999993928E-07 |
| Stage1-vs-Stage2 |
1.873430E-01 |
| Stage1-vs-Stage3 |
1.908810E-01 |
| Stage1-vs-Stage4 |
2.335700E-02 |
| Stage2-vs-Stage3 |
4.096500E-02 |
| Stage2-vs-Stage4 |
9.295500E-03 |
| Stage3-vs-Stage4 |
3.905400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.46149999996825E-06 |
| Normal-vs-AfricanAmerican |
1.354220E-01 |
| Normal-vs-Asian |
1.204740E-03 |
| Caucasian-vs-AfricanAmerican |
1.217160E-01 |
| Caucasian-vs-Asian |
7.534800E-01 |
| AfricanAmerican-vs-Asian |
2.258000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6122999999979E-05 |
| Normal-vs-Female |
5.96720000000106E-05 |
| Male-vs-Female |
2.272600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.632800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.58960000002018E-06 |
| Normal-vs-Age(61-80Yrs) |
2.249200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.524400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.094200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.614200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.839600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.182000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.628000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.266000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.835250E-03 |
| Classical-VS-Follicular |
8.654400E-01 |
| Classical-VS-Other |
2.091600E-01 |
| Classical-VS-Normal |
1.552010E-04 |
| Tall-VS-Follicular |
8.077600E-03 |
| Tall-VS-Other |
9.967600E-01 |
| Tall-VS-Normal |
3.06889999968085E-07 |
| Follicular-VS-Other |
2.689200E-01 |
| Follicular-VS-Normal |
5.442000E-03 |
| Other-VS-Normal |
1.086410E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.208790E-04 |
| Normal-vs-N1 |
4.5774000000387E-06 |
| N0-vs-N1 |
1.259810E-01 |
|
|
